Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion

ConditionPleural Effusion, Malignant

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAssiut University

About this trial

To evaluate the ability of cancer ratio and pleural fluid markers to discriminate between malignant and non malignant effusion

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients (100 cases) with exudative pleural effusion who will be admitted to Department of Chest diseases and Tuberculosis, Assiut University Hospital

Disqualifiers

Age ˂ 18 years

Refusal to participate in the study

Trial population

patients with exudative pleural effusion who will be admitted to Department of Chest diseases and Tuberculosis, Assiut University Hospital

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

pleural markers
Diagnostic test
Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Differentiate between malignant and non malignant pleural effusion by pleural markers

using pleural markers

Time frame

Baseline

Secondary outcomes

Time saving

decrease the need for invasive maneuvers for diagnosis * decrease length of hospital stay * decrease the development of complications

Time frame

Baseline

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: